New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs for millions of people.

FDA crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many By . Deidre McPhillips. Updated May 21, 2025, 12:39 PM ET. PUBLISHED May 21, 2025, 7:00 AM ET.

U.S. telehealth platform looks to take advantage of Ozempic patent expiring in January, while four manufacturers filed for ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 medication injected daily instead of weekly.